Dear Colleagues: A few days ago the US National Cancer Institute (NCI) released initial results from the large-scale lung cancer screening trial; the National Lung Screening Trial (NLST), which demonstrated a 20% reduction in lung cancer mortality. This result will certainly lead to a significant change in clinical practice (see below).
Dear Colleagues: Annoucement for IASLC Fellowship Award, Young Investigators Award and Prevent Cancer Foundation Award – see below. The announcement is translated to Chinese and Japanese and will be e-mailed to the respective members. Maybe please ask the Chinese and Japanese members to be mentors for fellows and help with the application. Deadline, January 2010.
I hope you had a good summer season (for those of you in this seasonal period)!
IASLC is now preparing for an active 2010-2011 season. Nominations of new candidates for the IASLC Board of Directors are now on call (see below).
The announcement for the IASLC World Conference 2017 has been released (see below).
The Journal of Thoracic Oncology is doing progress and new features are implemented (see below).
The IASLC proudly announces these recent successes:
The Journal of Thoracic Oncology has just been recognized with a 2009 impact factor of 4.5, an increase from 3.5 in 2008. Great credit to the Chief Editor, Jim Jett, the Associate Editors and to the IASLC!
The recent IASLC/ESMO Lung Cancer Meeting in Geneva was a huge success with about 1700 participants. The IASLC and ESMO have recognized the success of those meetings and have agreed upon continued joint Lung Cancer Meetings every 2nd year.
The IASLC Nominating Committee is preparing the Election of new Directors in 2011. Names of potential candidates can be forwarded by the IASLC members (see below).
Dear Colleagues: Since the last Newsletter several important things have happened; After successful meetings on lung cancer biology (with AACR) in San Diego and on Targeted Therapies in Santa Monica, we are now looking forward to see many of you in Geneva next week to the IASLC/ESMO Lung Cancer Meeting.
Important decisions were made at the last Board of Directors meeting in California, November 1-2, 2009. After long strategic discussions and evaluation, the Board of Directors decided to establish an independent permanent headquarters established in Denver, Colorado. The Board of Directors is currently with the help of an external company planning the infrastructure necessary to operate this headquarters. The establishment of the headquarters in Denver is expected to be completed by July 2010. At the same time the Board of Directors is considering to establishing regional offices. The IASLC members can send questions, comments or concerns to the IASLC Office.